近期,2025年欧洲肿瘤内科学会(ESMO)年会正式召开。作为全球最具学术影响力的肿瘤学盛会之一,ESMO向来是创新药企业披露核心品种重磅临床数据的重要平台,各大药企借此不仅能提升自身知名度与行业影响力,更可拓展合作机遇。从投资视角观察,过往案例显示,在ESMO大会披露重磅单品临床数据的企业,其股价往往会受到积极催化。基于此,该大会或可以视作为全球创新药投资领域的关键事件之一。港股上市仅一周的...
Source Link近期,2025年欧洲肿瘤内科学会(ESMO)年会正式召开。作为全球最具学术影响力的肿瘤学盛会之一,ESMO向来是创新药企业披露核心品种重磅临床数据的重要平台,各大药企借此不仅能提升自身知名度与行业影响力,更可拓展合作机遇。从投资视角观察,过往案例显示,在ESMO大会披露重磅单品临床数据的企业,其股价往往会受到积极催化。基于此,该大会或可以视作为全球创新药投资领域的关键事件之一。港股上市仅一周的...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.